Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Omnicell, Inc. (OMCL)

36.65 -0.23 (-0.62%)
At close: October 30 at 4:00:01 PM EDT
36.65 0.00 (0.00%)
After hours: October 30 at 4:00:16 PM EDT
Trade OMCL on Coinbase
OMCL Q3 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for OMCL
  • Previous Close 36.88
  • Open 37.13
  • Bid 26.68 x 200
  • Ask 45.49 x 200
  • Day's Range 35.50 - 37.30
  • 52 Week Range 31.75 - 55.00
  • Volume 785,542
  • Avg. Volume 605,296
  • Market Cap (intraday) 1.672B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 43.63
  • EPS (TTM) 0.84
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 57.86
  • Zacks Rating Neutral

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

www.omnicell.com

3,580

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

OMCL
19.09%
S&P 500 (^GSPC)
10.73%

1-Year Return

OMCL
9.14%
S&P 500 (^GSPC)
11.11%

3-Year Return

OMCL
3.82%
S&P 500 (^GSPC)
81.91%

5-Year Return

OMCL
79.43%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 307.85M
Earnings 11.04M
Profit Margin 3.59%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
300M
0.0%
2.0%
4.0%
6.0%

Analyst Insights

View More

Analyst Price Targets

45.00
57.86 Average
36.65 Current
70.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/31/2026
Analyst Freedom Capital Markets
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 60 -> 55

Statistics

View More

Valuation Measures

Annual
As of 10/29/2026
  • Market Cap

    1.68B

  • Enterprise Value

    1.58B

  • Trailing P/E

    43.90

  • Forward P/E

    --

  • PEG Ratio (current)

    0.65

  • Price/Sales (ttm)

    1.36

  • Price/Book (mrq)

    1.30

  • Enterprise Value/Revenue

    1.26

  • Enterprise Value/EBITDA

    11.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.59%

  • Return on Assets (ttm)

    2.22%

  • Return on Equity (ttm)

    3.52%

  • Revenue (ttm)

    1.24B

  • Net Income Avi to Common (ttm)

    44.66M

  • Diluted EPS (ttm)

    0.84

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    314.86M

  • Total Debt/Equity (mrq)

    14.40%

  • Levered Free Cash Flow (ttm)

    154.91M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

36.65 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • What does Argus have to say about OMCL?

    OMNICELL INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

  • What does Argus have to say about OMCL?

    OMNICELL INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

  • Raising target price to $35.00

    OMNICELL INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

  • Raising target price to $34.00

    OMNICELL INC has an Investment Rating of HOLD; a target price of $34.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: